1. Home
  2. BMM vs PROF Comparison

BMM vs PROF Comparison

Compare BMM & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BMM

Blue Moon Metals Inc. Common Shares

N/A

Current Price

$5.76

Market Cap

316.1M

Sector

N/A

ML Signal

N/A

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

HOLD

Current Price

$6.19

Market Cap

270.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMM
PROF
Founded
2007
N/A
Country
Canada
Canada
Employees
27
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
316.1M
270.7M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
BMM
PROF
Price
$5.76
$6.19
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
104.6K
352.4K
Earning Date
02-27-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
25.89
EPS
N/A
1.41
Revenue
N/A
$16,098,000.00
Revenue This Year
N/A
$115.41
Revenue Next Year
N/A
$60.63
P/E Ratio
N/A
$4.47
Revenue Growth
N/A
50.73
52 Week Low
$3.47
$3.90
52 Week High
$6.56
$8.95

Technical Indicators

Market Signals
Indicator
BMM
PROF
Relative Strength Index (RSI) 57.89 52.14
Support Level $4.79 $5.81
Resistance Level $5.97 $7.18
Average True Range (ATR) 0.43 0.47
MACD -0.05 0.11
Stochastic Oscillator 56.97 74.11

Price Performance

Historical Comparison
BMM
PROF

About BMM Blue Moon Metals Inc. Common Shares

Blue Moon Metals Inc is a Canadian exploration stage company which is focused on the exploration and development of mineral resource properties. The company is advancing its Blue Moon polymetallic deposit which contains zinc, gold, silver, and copper. The company also holds the Yava polymetallic project in Nunavut that is in the same volcanic lithologies and south of Glencore's Hackett River deposit. The company is focusing on advancing the Blue Moon and Yava properties.

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

Share on Social Networks: